Current anesthesia care guidance for diabetic patients taking GLP-1 agonists Lets examine the 2023 consensus-based practice guidelines published by the ASA regarding the anesthetic considerations of the GLP-1RAs: GLP-1 agonists are associated with many adverse effects, such as nausea, vomiting, delayed gastric emptying, and abdominal pain and bloating
GIP and glucagon receptor activation may contribute through effects on nutrient sensing and metabolic fuel availability
Small high-technology firms are encouraged to submit proposals to the Department of Defense for R&D projects with both military and commercial applications via the 2014.3 Small Business Innovative Research (SBIR) Solicitation
Structures data suggests smaller biotech players are capable of competing on efficacy, at least in early- to mid-stage studies
Kutoh E, Hirate M, Ikeno Y
If symptoms include worsening pain, weakness, numbness, fever, unexplained weight loss, chest pain, severe fatigue, or new neurologic symptoms, patients should seek medical evaluation instead of relying on wellness therapies alone